Field cancerization: Why late 'recurrent' ovarian cancer is not recurrent

American Journal of Obstetrics and Gynecology

Volumn 178, Issue 4, 1998, Pages 641-649

  Buller, R E ^a   Skilling, J S ^a   Sood, A K ^a   Plaxe, S ^a   Baergen, R N ^a   Lager, D J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Clonality; Molecular genetics; Ovarian cancer

Indexed keywords

CANCER RECURRENCE; CLONAL ANERGY; CONFERENCE PAPER; HUMAN; HUMAN TISSUE; MOLECULAR GENETICS; OVARY CANCER; PERITONEAL CAVITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; TUMOR GROWTH; X CHROMOSOME INACTIVATION;

EID: 0031958138     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(98)70473-9     Document Type: Conference Paper

References (29)

1. DM Gershenson JJ Kavanagh LJ Copeland CA Stringer M Morris JT. Wharton Re-treatment of patients with recurrent epithelial ovarian cancer with cisplatin-based chemotherapy Obstet Gynecol 73 1989 798 802
2. M Markman R Rothman T Hakes B Reichman W Hoskins S Rubin Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin J Clin Oncol 9 1991 389 393
3. LB Travis RE Curtis JD Boice Jr CE Platz BF Hankey JF Fraumeni Jr. Second malignant neoplasms among long-term survivors of ovarian cancer Cancer Res 56 1996 1564 1570
4. DM Shin JS Lee SM Lippman JJ Lee ZN Tu G Choi p53 expression: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma J Natl Cancer Inst 88 1996 519 529
5. JD Bloss S Liao RE Buller A Manetta ML Berman S McMeekin Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary Gynecol Oncol 50 1993 347 351
6. IJ Jacobs MF Kohler RW Wiseman JR Marks R Whitaker BAJ Kerns Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivation J Natl Cancer Inst 84 1992 1793 1798
7. C-H Mok SW Tsao RC Knapp PM Fishbaugh CC. Lau Unifocal origin of advanced human epithelial ovarian cancers Cancer Res 52 1992 5119 5122
8. J Kupryjanczyk AD Thor R Beuchamp C Poremba RE Scully DW. Yandell Ovarian, peritoneal, and endometrial serous carcinoma: clonal origin of multifocal disease Mod Pathol 9 1996 166 173
9. TW Park JC Felix TC Wright Jr. X chromosome inactivation and microsatellite instability in early and advanced bilateral ovarian carcinomas Cancer Res 55 1995 4793 4796
10. DL Slaughter HW Southwick W. Smejkal Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin Cancer 6 1953 963 968
11. MG Muto WR Welch SC-H Mok CA Bandera PM Fishbaugh SW Tsao Evidence for a multifocal origin of papillary serous carcinoma of the peritoneum Cancer Res 55 1995 490 492
12. JS Skilling A Sood T Niemann DJ Lager RE. Buller An abundance of p53 null mutations in ovarian carcinoma Oncogene 13 1996 117 123
13. JS Skilling K Powills DJ Lager B Anderson J Sorosky RE. Buller p53 allelotypes and enhanced detection of allelic loss in ovarian cancer: lack of correlation with familial and clinical factors Gynecol Oncol 61 1996 180 188
14. RE Buller JS Skilling S Kaliszewski T Niemann B. Anderson Absence of significant germ line p53 mutations in ovarian cancer patients Gynecol Oncol 58 1995 368 374
15. RE Buller A Sood C Fullenkamp J Sorosky K Powills B. Anderson The influence of the p53 codon 72 polymorphism on ovarian carcinogenesis and prognosis Cancer Gene Ther 4 1997 239 245
16. MF. Lyon Gene action in the X-chromosome of the mouse (Mus musculus L) Nature 190 1961 372 373
17. RC Allen HY Zoghbi AB Moseley HM Rosenblatt JW. Belmont Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation Am J Hum Genet 51 1992 1229 1239
18. A Sood R. Buller Genomic instability in ovarian cancer: a reassessment using arbitrarily primed polymerase chain reaction Oncogene 13 1996 2499 2504
19. J Simard P Tonin F Durocher K Morgan J Remmens S Gingras Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families Nature Genet 8 1994 392 398
20. A Sood JS Skilling RE. Buller Ovarian cancer genomic instability correlates with p53 frameshift mutations Cancer Res 57 1997 1047 1049
21. JD Woodruff CG. Julian Multiple malignancy in the upper genital canal Am J Obstet Gynecol 93 1969 810 822
22. RE Buller B Anderson JP Connor R. Robinson Familial ovarian cancer Gynecol Oncol 51 1993 160 166
23. SC Rubin I Benjamin K Behbakht H Takahashi MA Morgan VA LiVolsi Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1 N Engl J Med 335 1996 1413 1416
24. RE Buller T Niemann JP Connor RC Squatrito JS Skilling B. Anderson Isolation and preliminary characterization of an ovarian carcinoma cell line from a patient with familial ovarian cancer Gynecol Oncol 56 1995 39 44
25. M Lu SD Conzen CN Cole BA. Arrick Characterization of funcational messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells Cancer Res 56 1996 4578 4581
26. JK Tobacman MH Greene MA Tucker J Costa R Kase JF Fraumeni Jr. Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families Lancet 2 1982 795 797
27. LA. Loeb Microsatellite instability: marker of a mutator phenotype in cancer Cancer Res 54 1994 5059 5063
28. PA Jones JD. Buckley The role of DNA methylation in cancer Adv Cancer Res 54 1990 1 23
29. F Janicke M Holscher W Kuhn R von Hugo L Pache JR Siewert Radical surgical procedure improves survival time in patients with recurrent ovarian cancer Cancer 70 1992 2129 2136